Cells succumbing to stress via regulated cell death (RCD) can initiate an adaptive immune
response associated with immunological memory, provided they display sufficient …

Acute myeloid leukemia (AML) is a hematological malignancy characterized by uncontrolled
proliferation, differentiation arrest, and accumulation of immature myeloid progenitors. …

Myocardial infarction causes almost 7.3 million deaths each year worldwide. However,
current treatments are more palliative than curative. Presently, cell and protein therapies are …

We have previously provided the first genetic evidence that angiotensin converting enzyme
2 (ACE2) is the critical receptor for severe acute respiratory syndrome coronavirus (SARS-…

Background For patients with smoldering multiple myeloma, the standard of care is observation
until symptoms develop. However, this approach does not identify high-risk patients who …

In the last years, microRNAs (miRNA) have emerged as new molecular players involved in
carcinogenesis. Deregulation of miRNAs expression has been shown in different human …

Standard first-line treatment for elderly multiple myeloma (MM) patients ineligible for stem
cell transplantation is melphalan plus prednisone (MP). However, complete responses (CRs) …

Nod2, a member of the Apaf1/Nod protein family, confers responsiveness to bacterial products
and activates NF-κB, a transcription factor that plays a central role in innate immunity. …

Aim Experimental animal studies suggest that the use of skeletal myoblast in patients with
myocardial infarction may result in improved cardiac function. The aim of the study was to …

Bcr-Abl–expressing leukemic cells are highly resistant to apoptosis induced by chemotherapeutic
drugs. Although a number of signaling molecules have been shown to be activated by …